21 May 2009
Ann Transplant 2009; 14(1): 45-45 :: ID: 880364
Background: The aim of simultaneous pancreas and kidney transplantation (SPK) performed in patients with insulin dependent diabetes mellitus (IDDM) and chronic renal failure (CRF) is to increase their health status, survival and the quality of life (QOL). However, SPK is related to an increased risk of postoperative complications compared to kidney transplantation alone (KTA). The aim of the study was to compare QOL of patients with IDDM and CRF subjected to SPK or KTA.
Material/Methods: Twenty patients after successful SPK with good function of both grafts as well as 16 patients after KTA and those who lost pancreatic graft shortly after SPK were analyzed. Minimal observation time was 6 months. QOL was evaluated using Polish version of Kidney Disease and Quality of Lifeâ„¢ Short Form (KDQOL-SFâ„¢).
Results: Observation time in SPK group was shorter than in KTA group (25 vs. 45 months). Analyzed groups did not differ in regard to patients' age during transplantation, duration of diabetes and dialysis treatment before transplantation. Patients after SPK reported higher QOL in regard to the effects of kidney disease and pain (87 vs. 78% and 100 vs. 62% respectively). Moreover, tendencies towards statistical significance were observed in differences between the groups in regard to cognitive function, physical function and general health (93 vs. 80%, 90 vs. 80% i 60 vs. 47% respectively).
Conclusions: QOL of patients with IDDM and CRF subjected to successful SPK is higher in regard to selected parameters evaluated in KDQOL-SFâ„¢ compared to patients subjected to KTA.
Keywords: Kidney Transplantation
Most Viewed Current Articles
26 Jan 2022 : Review articleRecurrence of Hepatocellular Carcinoma After Liver Transplantation: Risk Factors and Predictive Models
Ann Transplant 2022; 27:e934924
24 Aug 2021 : Review articleNormothermic Machine Perfusion (NMP) of the Liver – Current Status and Future Perspectives
Ann Transplant 2021; 26:e931664
29 Dec 2021 : Original articleEfficacy and Safety of Tacrolimus-Based Maintenance Regimens in De Novo Kidney Transplant Recipients: A Sys...
Ann Transplant 2021; 26:e933588